[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Medical Care Ag ADR (FMS)

Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis

BAD HOMBURG, Germany , June 3, 2026 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the global launch...

FMS : 22.66 (-2.50%)
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million

BAD HOMBURG, Germany , May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch...

FMS : 22.66 (-2.50%)
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026

BAD HOMBURG, Germany , May 27, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, presents new research...

FMS : 22.66 (-2.50%)
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months

BAD HOMBURG, Germany , May 26, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, intends to execute a new...

FMS : 22.66 (-2.50%)
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care

BAD HOMBURG, Germany , May 21, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, has completed a milestone...

FMS : 22.66 (-2.50%)
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer

BAD HOMBURG, Germany , May 20, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease,...

FMS : 22.66 (-2.50%)
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed

BAD HOMBURG, Germany , May 5, 2026 /PRNewswire/ -- "Fresenius Medical Care delivered continued operational and financial progress in the first quarter, with organic revenue growth, improved profitability...

FMS : 22.66 (-2.50%)
Fresenius Medical Care's Profitability Streak Meets the HDF Rollout Reality Check

Barchart Research What to Expect from FMS Earnings FMS Generated May 4, 2026 Current Price $22.65 EPS Estimate $$0.59 Consensus Rating Hold Average Move 4.55% Fresenius Medical Care's Profitability Streak...

FMS : 22.66 (-2.50%)
DaVita Stock: Is DVA Outperforming the Health Care Sector?

DaVita has outperformed the Health Care sector recently, but analysts are cautious about the stock’s prospects.

XLV : 160.19 (-0.09%)
FMS : 22.66 (-2.50%)
DVA : 216.54 (-0.23%)
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

BAD HOMBURG, Germany , Feb. 24, 2026 /PRNewswire/ -- "Fresenius Medical Care closed a milestone year marked by outstanding profitability gains. Over the past three years, we built a stronger and...

FMS : 22.66 (-2.50%)

Barchart Exclusives

Mark Cuban Outlines ‘Multiple Ways’ AI Industry Could Collapse If People View It As ‘Toxic’ — But The Billionaire Remains Bullish
Mark Cuban says AI could collapse if users view leading models as “toxic,” but remains bullish long term, arguing adoption—not spending—will determine the industry’s future. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.